Company / Net Debt per Share
West Pharmaceutical Services Net Debt per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
-$8.14
FY2025
5-year range
-$9.24 / -$3.84
FY2021-FY2025
Trend
-112.2%
vs FY2024
Sector context
#92 of 98
Health Care
What the data says
Among 98 Health Care companies, West Pharmaceutical Services is in the top 6% for net debt per share. Net Debt per Share has fluctuated over the past 10 years, ranging from $-9.24 in FY2022 to $-0.37 in FY2016.
Based on SEC 10-K filings.
-8.14 in FY2025.
Increased from $-8.73 to $-8.14 over the past 2 years.
Health Care sector context is included.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 6% in Health CareTop 6% of 98This company -$8.14 Sector average $7.39
▼
-210.2% below sector average
Key checks
Key Insights
- In FY2025, net debt per share decreased 112.2% year-over-year.
- Ranks #92 out of 98 companies in the Health Care sector.
- Peak net debt per share was recorded in FY2016.
- Lowest net debt per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 3.45 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$8.14 | -112.2% |
| FY2024 | -$3.84 | +56.1% |
| FY2023 | -$8.73 | +5.5% |
| FY2022 | -$9.24 | -34.1% |
| FY2021 | -$6.89 | -520.8% |
| FY2020 | -$1.11 | +54.8% |
| FY2019 | -$2.45 | -28.3% |
| FY2018 | -$1.91 | -259.3% |
| FY2017 | -$0.53 | -44.1% |
| FY2016 | -$0.37 | -138.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026